The purpose of this study is to confirm the long term safety and efficacy of enzalutamide in patients.

Inclusion Criteria:

• no history of treatment with enzalutamide

Exclusion Criteria:

-

Patients with castration-resistant prostate cancer

Access to anonymized individual participant level data will not be provided for this trial. Further details on Astellas' data sharing policy can be found at https://www.clinicaltrials.astellas.com/transparency/.